Twelve Years of Accessible Clinical Trial Support: Inside the Prima Nexus Clinical Research Portfolio
Prima Nexus built a practical, flexible and affordable clinical research support team for universities, start-ups and local innovators that do not need a large CRO.
· Company news
KUALA LUMPUR, 21 July 2026: Twelve years ago, Prima Nexus saw a gap in Malaysia's clinical trial market. Many researchers and companies wanted to run clinical studies, but the cost was simply too high. Not every project needed a large contract research organisation (CRO); many only needed the right team and the right support. So Prima Nexus built one.
Built for the projects a large CRO overlooks
The aim was simple: make clinical trials accessible, especially for universities, start-ups and local innovators, with a clinical research support team that is practical, flexible and affordable.
A growing record across health areas
Over the years, the team has supported successful studies across many areas, including gut health, healthy ageing, cardiovascular health, prediabetes, glucose metabolism, fatty liver disease and endometriosis.
Prima Nexus supports Phase I to IV biomarker work, feasibility and site logistics, so that a trial keeps moving. Studies can also draw on the company's ELISA and Luminex biomarker platform and its regulatory and grant support.
“Every completed study started with one simple idea: research should be accessible to everyone with a great innovation. We are proud of how far we have come, and even more excited for what is ahead.”
Nura Samsuddin, Managing Partner, Prima Nexus
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. Our collaborations have supported more than 150 papers in peer-reviewed journals and research teams at more than 40 institutions across Malaysia. More about Prima Nexus.
Media and partnership enquiries
Prima Nexus Sdn Bhd, Level 2, Mercu Aspire, 59200 KL Eco City, Kuala Lumpur, Malaysia. Email info@primanexus.com.my or WhatsApp 017-305 1076.